These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Silent bleeding in children and adolescents with immune thrombocytopenia: relation to laboratory parameters and health related quality of life. Tantawy AA; Elsherif NHK; Kenny MA; Aboulfotouh KA; Hassan AE; Kabil ME J Thromb Thrombolysis; 2020 Aug; 50(2):258-266. PubMed ID: 31956939 [TBL] [Abstract][Full Text] [Related]
31. Severe bleeding in idiopathic thrombocytopenic purpura. Bolton-Maggs P J Pediatr Hematol Oncol; 2003 Dec; 25 Suppl 1():S47-51. PubMed ID: 14668640 [TBL] [Abstract][Full Text] [Related]
32. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity. Güngör T; Arman Bilir Ö; Koşan Çulha V; Güngör A; Kara A; Azık FM; Yaralı HN Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618 [TBL] [Abstract][Full Text] [Related]
33. Symptomatic corpus luteum hemorrhage in adolescent females with ITP. Yelak A; From A; Gilad O; Brik Simon D; Rubin S; Cohen M; Amarilyo G; Levin C; Bakry D; Izraeli S; Tamary H; Yacobovich J; Steinberg-Shemer O Eur J Pediatr; 2024 Jul; 183(7):2893-2897. PubMed ID: 38602530 [TBL] [Abstract][Full Text] [Related]
34. Recommendations for the management of acute immune thrombocytopenia in children. A Consensus Conference from the Italian Association of Pediatric Hematology and Oncology. Russo G; Parodi E; Farruggia P; Notarangelo LD; Perrotta S; Casale M; Cesaro S; Del Borrello G; Del Vecchio GC; Giona F; Gorio C; Ladogana S; Lassandro G; Marzollo A; Maslak K; Miano M; Nardi M; Palumbo G; Rossi F; Spinelli M; Tolva A; Saracco P; Ramenghi U; Giordano P Blood Transfus; 2024 May; 22(3):253-265. PubMed ID: 37677093 [TBL] [Abstract][Full Text] [Related]
35. Idiopathic thrombocytopenic purpura: current issues for pathogenesis, diagnosis, and management in children and adults. George JN Curr Hematol Rep; 2003 Sep; 2(5):381-7. PubMed ID: 12932309 [TBL] [Abstract][Full Text] [Related]
36. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination. Baba Y; Sakai H; Kabasawa N; Harada H Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701 [TBL] [Abstract][Full Text] [Related]
37. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination]. Sato K; Anayama M; Sumi M; Kobayashi H Rinsho Ketsueki; 2021; 62(12):1688-1693. PubMed ID: 35022338 [TBL] [Abstract][Full Text] [Related]
38. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review. Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217 [TBL] [Abstract][Full Text] [Related]